Get 40% Off
💰 Warren Buffett reveals a $6.72 billion stake in ChubbCopy Portfolios

Cadence (CDNS) Reports Q4: Everything You Need To Know Ahead Of Earnings

Published 2024-02-11, 02:00 a/m
Cadence (CDNS) Reports Q4: Everything You Need To Know Ahead Of Earnings
CDNS
-
PTC
-
DOX
-

Stock Story -

Semiconductor design software provider Cadence Design Systems (NASDAQ:CDNS) will be reporting earnings tomorrow afternoon. Here's what to look for.

Last quarter Cadence reported revenues of $1.02 billion, up 13.4% year on year, beating analyst revenue expectations by 1.8%. It was a weak quarter for the company, with underwhelming revenue guidance for the next quarter.

Is Cadence buy or sell heading into the earnings? Find out by reading the original article on StockStory.

This quarter analysts are expecting Cadence's revenue to grow 17.9% year on year to $1.06 billion, in line with the 16.4% year-over-year increase in revenue the company had recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.33 per share.

Majority of analysts covering the company have reconfirmed their estimates over the last thirty days, suggesting they are expecting the business to stay the course heading into the earnings. The company only missed Wall St's revenue estimates once over the last two years, and has on average exceeded top line expectations by 2.4%.

Looking at Cadence's peers in the vertical software segment, some of them have already reported Q4 earnings results, giving us a hint of what we can expect. PTC (NASDAQ:PTC) delivered top-line growth of 18.1% year on year, beating analyst estimates by 2.3% and Doximity reported revenues up 17.4% year on year, exceeding estimates by 6.1%. PTC traded flat on the results, and Doximity was down 10.1%.

Read the full analysis of PTC's and Doximity's results on StockStory.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

There has been positive sentiment among investors in the vertical software segment, with the stocks up on average 8.2% over the last month. Cadence is up 13.4% during the same time, and is heading into the earnings with analyst price target of $289.4, compared to share price of $314.7.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.